Decreased TCR γδ T lymphocytes in patients with chronic obstructive pulmonary disease

J. Pons, J. Sauleda, J. M. Ferrer, V. Regueiro, B. Barcelo, A. Fuster, A. G. N. Agusti (Palma de Mallorca, Spain)

Source: Annual Congress 2003 - Markers, mediators and mechanisms of human lung injury
Session: Markers, mediators and mechanisms of human lung injury
Session type: Thematic Poster Session
Number: 621
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Pons, J. Sauleda, J. M. Ferrer, V. Regueiro, B. Barcelo, A. Fuster, A. G. N. Agusti (Palma de Mallorca, Spain). Decreased TCR γδ T lymphocytes in patients with chronic obstructive pulmonary disease. Eur Respir J 2003; 22: Suppl. 45, 621

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High percentage of CD8+ effector T lymphocytes in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002

Decreased pulmonary immunoregulatory/suppressor (CD4+CD25+) T-lymphocytes in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003

Increased CD4+ T-cell infiltration in bronchial epithelium of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007


A high probability of short-range interactions between fibrocytes and CD8 T cells in chronic obstructive pulmonary disease (COPD) lungs
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019

Exhausted T lymphocytes in chronic obstructive pulmonary disease: single-cell analysis of human lung tissue
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021


Lung dendritic cells from chronic obstructive pulmonary disease patients induce type 1 T regulatory cells
Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma
Year: 2012


Pulmonary dendritic cells from chronic obstructive pulmonary disease patients suppress lung immune responses through induction of regulatory T cells
Source: Annual Congress 2011 - T-cell subsets
Year: 2011

Levels of CD4CD25 T regulatory cells in bronchial mucosa and peripheral blood of chronic obstructive pulmonary disease indicate involvement of autoimmunity mechanisms
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019


The role of regulator and effector T lymphocytes in chronic obstructive pulmonary disease and lung cancer
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010

Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema
Source: Eur Respir J 2001; 17: 946-953
Year: 2001



A high probability of short-range interactions between fibrocytes and CD8+ T cells potentiates the inflammatory response in chronic obstructive pulmonary disease (COPD) lungs
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020


Analysis of peripheral blood lymphocytes in asthma and chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010

Regulator and effector T lymphocytes in late stages of non small cell lung cancer and chronic obstructive pulmonary disease
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012

T regulatory cells in exacerbation control of chronic obstructive pulmonary disease of mild and moderate stage
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012

Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 3-5
Year: 2004


Phenotype of T cells in lung tissue from smokers with or without chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 53s
Year: 2005

Pulmonary myeloid dendritic cell numbers, phenotype and response to lipopolysaccharide in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Year: 2010


Mechanisms of impaired anti-bacterial Th1 responses in patients with chronic obstructive pulmonary disease
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018




STAT4 activation in smokers and patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 78-85
Year: 2004



Accumulation of dendritic cells in small airways of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis
Year: 2007